MedPath

A randomised controlled trial to investigate the effect of exercise on both the communication between brain and body and symptoms of anxiety

Not Applicable
Recruiting
Conditions
Anxiety
Mental Health - Anxiety
Registration Number
ACTRN12620001296921
Lead Sponsor
niversity of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
125
Inclusion Criteria

Male or female aged between 18 and 45 years
Ability to provide written and informed consent
Ability to adhere to the study protocol
Spielberger trait anxiety score of greater than or equal to 40 (for moderate anxiety participants) OR less than or equal to 30 (for cross-sectional low anxiety controls)
Engaged in minimal organised sport or fitness activity (<1 per week for the last 6 months or more)

Exclusion Criteria

Evidence of severe acute or chronic medical disorders, including a neurological disorder, current or past history of a severe brain injury or severe respiratory disorder e.g. severe asthma, chronic obstructive pulmonary disease etc.
Past or current diagnoses of schizophrenia, bipolar disorder, drug addiction or psychosis
Colour blindness
Female patients who are pregnant or breastfeeding
Current significant suicidal ideation
Participants must be free of recreational drug and alcohol use at the time of testing
Presence of implanted cardiac pacemakers, hearing aids, insulin pumps or neurostimulators; intracranial metal clips; or metallic bodies in the eye (MRI safety)
Significant levels of smoking or vaping (more than once per week)
Any regular medication (except the oral contraceptive pill for women)
Contraindication to engaging in a progressive exercise program, as determined from a validated health-screening questionnaire (PAR-Q+).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath